Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Total revenues were $19.0 million for the third quarter of 2026Emrosi® revenues of $9.0 million increased 84% compared to the third quarter of 2025Company to hold conference call today at 4:30 p.m. ETSCOTTSDALE, Ariz., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation NASDAQ:DERM (“Jour…